Legal entity

Catalent

Company CTLT

Every one of those 1 sits in a single category, regulation. Catalent is most often covered alongside Controlled Substances Act, which appears in 1 of these 1 story. Catalent appears in 1 tracked Legal story from July 30, 2026. The tracked stories average 4 original sources each.

Last mentioned: Jul 30, 2026

Entity pulse

Recent coverage · Catalent

1 story
6 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Catalent

Every one of those 1 sits in a single category, regulation. Catalent is most often covered alongside Controlled Substances Act, which appears in 1 of these 1 story. Catalent appears in 1 tracked Legal story from July 30, 2026. The tracked stories average 4 original sources each.

Stories tracked
1
Sources per story
4

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Catalent. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Attorney General orders marijuana moved to Schedule III

    The AG issues an order rescheduling state‑licensed medical marijuana and establishing a novel federal registration system for state marijuana businesses.

  2. MMJ files DEA bulk‑manufacturer application

    MMJ International Holdings submits an application to manufacture active pharmaceutical ingredients for cannabinoid drugs, which remains pending nearly eight years later.

Stories mentioning Catalent 1

Regulation Neutral

After $10M FDA Pursuit, MMJ Challenges AG’s Marijuana Rescheduling as Flawed

A D.C. Circuit review of the Attorney General’s April 2026 order moving medical marijuana to Schedule III puts administrative law front and center. MMJ International Holdings argues the AG skipped required rulemaking and evidentiary hearings, threatening the integrity of the Controlled Substances Act’s scheduling process.

4 sources

Catalent is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.